Centre for Prevention and Health Services Research, National institute of Public Health and the Environment (RIVM), P.O. Box 1, 3720, BA Bilthoven, The Netherlands.
BMC Med Inform Decis Mak. 2013 Aug 16;13:91. doi: 10.1186/1472-6947-13-91.
Decisions to adopt a particular innovation may vary between stakeholders because individual stakeholders may disagree on the costs and benefits involved. This may translate to disagreement between stakeholders on priorities in the implementation process, possibly explaining the slow diffusion of innovations in health care. In this study, we explore the differences in stakeholder preferences for innovations, and quantify the difference in stakeholder priorities regarding costs and benefits.
The decision support technique called the analytic hierarchy process was used to quantify the preferences of stakeholders for nine information technology (IT) innovations in hospital care. The selection of the innovations was based on a literature review and expert judgments. Decision criteria related to the costs and benefits of the innovations were defined. These criteria were improvement in efficiency, health gains, satisfaction with care process, and investments required. Stakeholders judged the importance of the decision criteria and subsequently prioritized the selected IT innovations according to their expectations of how well the innovations would perform for these decision criteria.
The stakeholder groups (patients, nurses, physicians, managers, health care insurers, and policy makers) had different preference structures for the innovations selected. For instance, self-tests were one of the innovations most preferred by health care insurers and managers, owing to their expected positive impacts on efficiency and health gains. However, physicians, nurses and patients strongly doubted the health gains of self-tests, and accordingly ranked self-tests as the least-preferred innovation.
The various stakeholder groups had different expectations of the value of the nine IT innovations. The differences are likely due to perceived stakeholder benefits of each innovation, and less to the costs to individual stakeholder groups. This study provides a first exploratory quantitative insight into stakeholder positions concerning innovation in health care, and presents a novel way to study differences in stakeholder preferences. The results may be taken into account by decision makers involved in the implementation of innovations.
由于个体利益相关者可能对所涉及的成本和收益存在分歧,因此他们对采用特定创新的决策可能存在差异。这可能导致利益相关者在实施过程中的优先事项上存在分歧,这可能解释了医疗保健创新的缓慢扩散。在这项研究中,我们探讨了利益相关者对创新的偏好差异,并量化了利益相关者对成本和收益的优先事项的差异。
使用称为层次分析法的决策支持技术来量化利益相关者对医院护理中九种信息技术(IT)创新的偏好。创新的选择基于文献综述和专家判断。定义了与创新的成本和收益相关的决策标准。这些标准是效率提高、健康收益、对护理过程的满意度和所需投资。利益相关者判断决策标准的重要性,然后根据他们对创新在这些决策标准上的表现的期望对所选 IT 创新进行优先级排序。
利益相关者群体(患者、护士、医生、管理人员、医疗保健保险公司和政策制定者)对所选创新有不同的偏好结构。例如,自我测试是医疗保健保险公司和管理人员最期望的创新之一,因为它们预计对效率和健康收益有积极影响。然而,医生、护士和患者强烈怀疑自我测试的健康收益,因此将自我测试列为最不优先的创新。
不同的利益相关者群体对九种 IT 创新的价值有不同的期望。这些差异可能归因于每个创新的利益相关者感知利益,而不是归因于对个别利益相关者群体的成本。这项研究首次提供了对医疗保健创新中利益相关者立场的探索性定量见解,并提出了一种研究利益相关者偏好差异的新方法。决策者可以考虑这些结果,以参与创新的实施。